Stock Splits
By The Online Investor Staff, updated Tue., Dec. 6, 8:41 AM
| This Slide: #3 of 25 |
Slide #3. Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) — 1 for 10 Reverse Split
Announced:
11/30/2022
Stock Split:
1 for 10
Record Date:
11/30/2022
Pay Date:
12/1/2022
PTPI Optionable?:
Yes
Petros Pharmaceuticals is a pharmaceutical company focused on men's health therapeutics. Co.'s operating segments are Prescription Medications and Medical Devices, which focus on the treatment of male erectile dysfunction (ED). The Prescription Medications segment consists primarily of Stendra®, which is a PDE-5 inhibitor prescription medication for the treatment of ED, and H100™, which is a topical formulation candidate for the treatment of Peyronie's disease. The Medical Devices segment consists primarily of vacuum erection devices, which are sold domestically and internationally. 
PTPI Detailed Information Page & Split History »
|
|||||||||||||||
Open the PTPI Page at The Online Investor (in a new window) »
 Free PTPI Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
